| Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory … D Strumberg, H Richly, RA Hilger, N Schleucher, S Korfee, M Tewes, ... Journal of clinical oncology 23 (5), 965-972, 2005 | 1076 | 2005 |
| Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients B Aktas, M Tewes, T Fehm, S Hauch, R Kimmig, S Kasimir-Bauer Breast cancer research 11, 1-9, 2009 | 904 | 2009 |
| Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor … U Vanhoefer, M Tewes, F Rojo, O Dirsch, N Schleucher, O Rosen, ... Journal of Clinical Oncology 22 (1), 175-184, 2004 | 382 | 2004 |
| Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies M Tewes, B Aktas, A Welt, S Mueller, S Hauch, R Kimmig, ... Breast cancer research and treatment 115, 581-590, 2009 | 277 | 2009 |
| Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients B Aktas, V Müller, M Tewes, J Zeitz, S Kasimir-Bauer, CR Loehberg, ... Gynecologic oncology 122 (2), 356-360, 2011 | 156 | 2011 |
| Fatigue, barriers to physical activity and predictors for motivation to exercise in advanced Cancer patients J Frikkel, M Götte, M Beckmann, S Kasper, J Hense, M Teufel, M Schuler, ... BMC palliative care 19, 1-11, 2020 | 118 | 2020 |
| COVID-19-related fear and health-related safety behavior in oncological patients V Musche, A Bäuerle, J Steinbach, A Schweda, M Hetkamp, B Weismüller, ... Frontiers in Psychology 11, 1984, 2020 | 102 | 2020 |
| Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients B Aktas, S Kasimir-Bauer, V Müller, W Janni, T Fehm, D Wallwiener, ... BMC cancer 16, 1-8, 2016 | 95 | 2016 |
| RNA profiles of circulating tumor cells and extracellular vesicles for therapy stratification of metastatic breast cancer patients C Keup, P Mach, B Aktas, M Tewes, HC Kolberg, S Hauch, ... Clinical chemistry 64 (7), 1054-1062, 2018 | 72 | 2018 |
| Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study M Tewes, N Schleucher, W Achterrath, HJ Wilke, S Frings, S Seeber, ... Annals of oncology 14 (9), 1442-1448, 2003 | 62 | 2003 |
| Gene expression signatures in circulating tumor cells correlate with response to therapy in metastatic breast cancer M Bredemeier, P Edimiris, P Mach, M Kubista, R Sjöback, E Rohlova, ... Clinical chemistry 63 (10), 1585-1593, 2017 | 58 | 2017 |
| A systematic review of the safety, feasibility and benefits of exercise for patients with advanced cancer N De Lazzari, T Niels, M Tewes, M Goette Cancers 13 (17), 4478, 2021 | 57 | 2021 |
| Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course … M Bredemeier, P Edimiris, M Tewes, P Mach, B Aktas, D Schellbach, ... Oncotarget 7 (27), 41677, 2016 | 47 | 2016 |
| Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patients C Keup, K Benyaa, S Hauch, M Sprenger-Haussels, M Tewes, P Mach, ... Cellular and Molecular Life Sciences 77 (3), 497-509, 2020 | 46 | 2020 |
| Mental health burden of German cancer patients before and after the outbreak of COVID-19: predictors of mental health impairment A Bäuerle, V Musche, K Schmidt, A Schweda, M Fink, B Weismüller, ... International journal of environmental research and public health 18 (5), 2318, 2021 | 43 | 2021 |
| Results of a phase I trial of the humanized anti epidermal growth factor receptor (EGFR) monoclonal antibody EMD 72000 in patients with EGFR expressing solid tumors M Tewes, N Schleucher, O Dirsch, K Schmid, O Rosen, H Arens, A Kovar, ... Proc Am Soc Clin Oncol 21, 95a, 2002 | 39 | 2002 |
| A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors K Mross, H Richly, N Schleucher, S Korfee, M Tewes, ME Scheulen, ... Annals of oncology 15 (8), 1284-1294, 2004 | 37 | 2004 |
| Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer C Keup, V Suryaprakash, S Hauch, M Storbeck, P Hahn, ... Genome Medicine 13 (1), 85, 2021 | 32 | 2021 |
| Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center M Wiesweg, S Ting, H Reis, K Worm, S Kasper, M Tewes, A Welt, H Richly, ... European Journal of Cancer 49 (15), 3076-3082, 2013 | 32 | 2013 |
| Symptoms during outpatient cancer treatment and options for their management M Tewes, F Baumann, M Teufel, C Ostgathe Deutsches Ärzteblatt International 118 (17), 291, 2021 | 31 | 2021 |
